| __timestamp | Catalent, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 598600000 | 1256834000000 |
| Thursday, January 1, 2015 | 615300000 | 1271973000000 |
| Friday, January 1, 2016 | 587600000 | 1173296000000 |
| Sunday, January 1, 2017 | 654600000 | 1274610000000 |
| Monday, January 1, 2018 | 752600000 | 1437534000000 |
| Tuesday, January 1, 2019 | 805100000 | 2201424000000 |
| Wednesday, January 1, 2020 | 983300000 | 2203504000000 |
| Friday, January 1, 2021 | 1352000000 | 2462160000000 |
| Saturday, January 1, 2022 | 1640000000 | 2783406000000 |
| Sunday, January 1, 2023 | 1060000000 | 2832257000000 |
| Monday, January 1, 2024 | 953000000 | 2832257000000 |
Unlocking the unknown
In the competitive landscape of the pharmaceutical industry, gross profit is a key indicator of a company's financial health and market position. Over the past decade, Takeda Pharmaceutical Company Limited has consistently outperformed Catalent, Inc. in terms of gross profit. From 2014 to 2024, Takeda's gross profit has shown a robust upward trend, peaking at approximately 2.83 trillion in 2023 and 2024. In contrast, Catalent's gross profit, while growing, reached its highest point in 2022 at around 1.64 billion, which is a mere fraction of Takeda's figures.
This stark difference highlights Takeda's dominant position in the market, with its gross profit being over 1,700% higher than Catalent's in recent years. As the pharmaceutical industry continues to evolve, these financial metrics provide valuable insights into the strategic positioning and operational efficiency of these two industry leaders.
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Takeda Pharmaceutical Company Limited and Incyte Corporation: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Takeda Pharmaceutical Company Limited vs Grifols, S.A.: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited vs Vericel Corporation: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends
Gross Profit Trends Compared: Catalent, Inc. vs Exelixis, Inc.
Key Insights on Gross Profit: Catalent, Inc. vs MorphoSys AG
Key Insights on Gross Profit: Catalent, Inc. vs HUTCHMED (China) Limited
Catalent, Inc. and MiMedx Group, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Catalent, Inc. vs Evotec SE